Abstract 1689: Next generation ConjuAll BCMA antibody-drug conjugates (ADCs) LCB14-2524 and LCB14-2516 show increased efficacy in preclinical models of multiple myeloma
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: LigaChem Biosciences, Inc. (South Korea)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148887575
Cites:
Cited by:
Related to:
